Literature DB >> 25490384

Β-catenin is involved in Bex2 down-regulation induced glioma cell invasion/migration inhibition.

Er Nie1, Xu Zhang2, Shao Xie2, Qiong Shi2, Jinxia Hu2, Qingming Meng2, Xiuping Zhou3, Rutong Yu4.   

Abstract

Previously, we found that brain expressed X-linked gene 2 (Bex2) regulates the invasion/migration ability of glioma cells. However, the mechanism of this effect remains unknown. In current study, we reported that Bex2 down-regulation inhibited glioma cell migration and invasion by decreasing the nucleus and cytoplasm protein level of β-catenin. We found that the protein levels of Bex2 and β-catenin were up-regulated and showed direct correlation in glioma tissues. Bex2 down-regulation significantly decreased β-catenin protein levels but not its mRNA levels. Furthermore, the decreased protein level of β-catenin was located in the nucleus and cytoplasm but not in the cell membrane. Further study found that the effects of Bex2 down-regulation on the invasion and migration of glioma cell could be reversed by β-catenin over-expression. Taken together, Bex2 affects the invasion and migration ability of glioma cells by regulating β-catenin.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bex2; Glioblastoma; Invasion; Migration; β-Catenin

Mesh:

Substances:

Year:  2014        PMID: 25490384     DOI: 10.1016/j.bbrc.2014.11.113

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT.

Authors:  Er Nie; Xin Jin; Weining Wu; Tianfu Yu; Xu Zhou; Zhumei Shi; Junxia Zhang; Ning Liu; Yongping You
Journal:  J Neurooncol       Date:  2017-04-19       Impact factor: 4.130

2.  PinX1 inhibits cell proliferation, migration and invasion in glioma cells.

Authors:  Peng-Jin Mei; Yan-Su Chen; Ying Du; Jin Bai; Jun-Nian Zheng
Journal:  Med Oncol       Date:  2015-02-20       Impact factor: 3.064

3.  Increased DKC1 expression in glioma and its significance in tumor cell proliferation, migration and invasion.

Authors:  Fa-An Miao; Kun Chu; Hai-Rong Chen; Meng Zhang; Pei-Cong Shi; Jin Bai; Yong-Ping You
Journal:  Invest New Drugs       Date:  2019-03-07       Impact factor: 3.850

4.  BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53.

Authors:  Er Nie; Xin Jin; Weining Wu; Tianfu Yu; Xu Zhou; Tongle Zhi; Zhumei Shi; Junxia Zhang; Ning Liu; Yongping You
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

5.  Diagnostic and prognostic value of the BEX family in lung adenocarcinoma.

Authors:  Zhong-Hao Zhang; Zhi-Yu Luan; Fei Han; Hong-Qiang Chen; Wen-Bin Liu; Jin-Yi Liu; Jia Cao
Journal:  Oncol Lett       Date:  2019-09-20       Impact factor: 2.967

6.  Silencing of brain-expressed X-linked 2 (BEX2) promotes colorectal cancer metastasis through the Hedgehog signaling pathway.

Authors:  Yinuo Tan; Yeting Hu; Qian Xiao; Yang Tang; Haiyan Chen; Jinjie He; Liubo Chen; Kai Jiang; Zhanhuai Wang; Ying Yuan; Kefeng Ding
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 6.580

7.  Overexpression of Forkhead Box L1 (FOXL1) Inhibits the Proliferation and Invasion of Breast Cancer Cells.

Authors:  Jiateng Zhong; Haijun Wang; Jian Yu; Jinghang Zhang; Hui Wang
Journal:  Oncol Res       Date:  2016-11-29       Impact factor: 5.574

8.  Up-regulation of brain-expressed X-linked 2 is critical for hepatitis B virus X protein-induced hepatocellular carcinoma development.

Authors:  Fuqiang Huang; Pei Cai; Yanan Wang; Xian Zhou; Hongyu Chen; Wenjun Liao; Yilei Mao; Xiaojun Zha; Hongbing Zhang; Zhongdong Hu
Journal:  Oncotarget       Date:  2017-07-22

Review 9.  Signaling pathways and mesenchymal transition in pediatric high-grade glioma.

Authors:  Michaël H Meel; Sophie A Schaper; Gertjan J L Kaspers; Esther Hulleman
Journal:  Cell Mol Life Sci       Date:  2017-11-21       Impact factor: 9.261

10.  β-catenin-mediated YAP signaling promotes human glioma growth.

Authors:  Yan Wang; Peng Pan; Zhaohao Wang; Yu Zhang; Peng Xie; Decheng Geng; Yang Jiang; Rutong Yu; Xiuping Zhou
Journal:  J Exp Clin Cancer Res       Date:  2017-09-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.